Datavault AI (NASDAQ: DVLT) has entered into a nonbinding letter of intent to acquire a 19.9% equity interest in DataMEDS AI Inc. (NASDAQ: MEDS) in exchange for expanding its existing technology license with the company. The proposed transaction matters because it would allow Datavault AI to retain ownership of its underlying intellectual property while potentially generating royalty revenue from commercialization of the licensed technologies. DataMEDS would assume commercialization costs, and Datavault AI would have the right to designate one director to the DataMEDS board following closing. The company believes a fourth-quarter 2026 closing is achievable, subject to due diligence, definitive agreements and customary closing conditions.
The strategic implications extend beyond the balance sheet. The proposed expanded license would build on DataMEDS’ existing PharmacyChain platform and EinsteinRx AI capabilities, incorporating Datavault AI Health technologies designed to support patient-controlled health data access, management, monetization and tokenization across pharmacy, laboratory, wearable and other health care environments. This positions Datavault AI at the intersection of AI, Web 3.0 and health care data, a space where patient-controlled data access is gaining regulatory and commercial attention. The initiative is part of broader efforts by DataMEDS to expand its health care technology capabilities through arrangements with several companies, including EOS Technology Holdings, Scilex Holding Company, HealthBridge Advisors and REBOOT Health AI. For Datavault AI, the deal structure is notable: by taking equity instead of a cash payment, the company aligns its upside with DataMEDS’ commercialization success while avoiding direct funding obligations. However, the letter of intent does not obligate either party to complete the transaction, and the nonbinding nature means significant execution risk remains. To view the full press release, visit https://ibn.fm/Q8IGK.
Datavault AI(TM) (NASDAQ: DVLT) is leading the way in AI-driven data experiences, valuation and monetization of assets in the Web 3.0 environment. The Company’s cloud-based platform provides comprehensive solutions with a collaborative focus in its Acoustic Sciences and Data Sciences divisions. The Company’s technology suite is fully customizable and offers AI- and machine-learning-based automation, third-party integration, detailed analytics and data, marketing automation and advertising monitoring. The Company is headquartered in Philadelphia, PA. Learn more about Datavault AI at https://dvlt.ai. The latest news and updates relating to DVLT are available in the company’s newsroom at https://ibn.fm/DVLT.
About DefenseWireNews DefenseWireNews (“DWN”) is a specialized communications platform with a focus on defense contractors, aerospace firms, cybersecurity leaders, advanced manufacturing innovators, and other mission-critical companies operating at the intersection of public markets and government demand. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, DWN is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, DWN brings its clients unparalleled recognition and brand awareness. DWN is where breaking news, insightful content and actionable information converge. Please see full terms of use and disclaimers on the DefenseWireNews website applicable to all content provided by DWN, wherever published or re-published: https://www.DefenseWireNews.com/Disclaimer.
